🇸🇪 Sweden Country × Condition
atrial fibrillation Clinical Trials in Sweden
Active clinical trials for atrial fibrillation with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇸🇪 Sweden
Active Trials in Sweden (4)
NCT05679024 Phase 3
Recruiting
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Enrollment
1,400 pts
Country
🇸🇪 Sweden
Region Stockholm
View Trial → NCT06399666
Recruiting
Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation
Enrollment
182 pts
Country
🇸🇪 Sweden
Vrinnevi Hospital
View Trial → NCT06315192
Recruiting
Stroke Alarm Efficacy Trial
Enrollment
500 pts
Country
🇸🇪 Sweden
Region Skane
View Trial → NCT05852704 Phase 3
Recruiting
SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Enrollment
800 pts
Country
🇸🇪 Sweden
Region Örebro County
View Trial → Frequently Asked Questions
How many atrial fibrillation clinical trials are active in Sweden?
There are currently 4 active clinical trials for atrial fibrillation with sites in Sweden, of which 4 are actively recruiting patients.
How can I join a atrial fibrillation clinical trial in Sweden?
To join a atrial fibrillation clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atrial fibrillation trials in Sweden?
Active atrial fibrillation trials in Sweden span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology